AdvisorShares Psychedelics ETF

PSIL
$18.04 0.00 (0.00%)
Dividend Yield 10.42%
Payout Frequency Quarterly

Dividend History

Pay DateAmountEx-DateRecord Date
December 29, 2025$1.682025-12-222025-12-22
September 29, 2025$0.022025-09-222025-09-22
June 27, 2025$0.012025-06-232025-06-23
March 28, 2025$0.162025-03-212025-03-21
December 30, 2024$0.052024-12-232024-12-23

Dividends Summary

Company News

Cannabis And Psychedelics Industries: Summer's Over, Where Are We?
Benzinga • David Feldman • August 28, 2024

The cannabis industry is awaiting a decision on rescheduling cannabis, which could impact its financial and regulatory landscape. The psychedelics industry is navigating the aftermath of a setback in MDMA research for PTSD, leading to potential consolidation and strategic shifts.

Top and Flop ETFs of the First Half
Zacks Investment Research • Sweta Killa • June 28, 2024

We have highlighted three ETFs each from the best and worst-performing zones in the first half of 2024.

Best and Worst ETF Zones of Q2
Zacks Investment Research • Sweta Killa • June 25, 2024

Technology remained the best-performing sector of the second quarter on the AI drive while energy lagged.

Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment
Benzinga • Aaron Bry • June 5, 2024

A panel of advisors to the Food and Drug Administration (FDA) rejected MDMA as a treatment for post-traumatic stress disorder (PTSD) on Tuesday, citing a lack of evidence that the benefits would outweigh the risks of introducing the psychedelic treatment to patients. Most stocks in the psychedelic space took a hit on Wednesday as a result of the ...

Top & Flop ETFs of August
Zacks Investment Research • Sanghamitra Saha • August 31, 2023

August was an average-to-downbeat month for investors, mainly due to rising rates.

Related Companies